Pasteurella multocida septic shock following liver transplantation treated with drotrecogin alpha (activated).

Pasteurella multocida septic shock following liver transplantation treated with drotrecogin alpha (activated). Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Pasteurella multocida septic shock following liver transplantation treated with drotrecogin alpha (activated). Abstract Text:

S Al-Sabah,P Goldberg,S T Qureshi,S Al-Sabah,P Goldberg,S T Qureshi,

Severe sepsis and progression to septic shock in solid organ transplant recipients is associated with a high mortality. We describe a fulminant case of septic shock in a liver transplant recipient caused by Pasteurella multocida, a gram-negative coccobacillus most commonly associated with domestic cats and dogs. P. multocida is a rare cause of bacteremia and has not been reported as a cause of septic shock following liver transplantation. In addition to standard therapy, the patient was managed with drotrecogin alpha (activated) recombinant activated protein C (APC), an evidence-based agent that has been shown to significantly improve outcome in severe sepsis in the non-transplant population. The known risk factors, clinical course, and outcomes of severe infection associated with P. multocida are also briefly reviewed. This case illustrates the need for transplant recipients and their healthcare providers to carefully consider the risk of severe infection associated with domestic animal exposure.

Pasteurella multocida septic shock following liver transplantation treated with drotrecogin alpha (activated). Publishing Authors By Initials

S Al-Sabah,P Goldberg,ST Qureshi,S Al-Sabah,P Goldberg,ST Qureshi,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Pasteurella multocida septic shock following liver transplantation treated with drotrecogin alpha (activated). Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Transplant infectious disease : an official journa

VOLUME: 9

Page Numbers: 233-6

Journal Abbreviation:

ISSN: 1398-2273

DAY: 13

MONTH: Sep

YEAR: 2007

Pasteurella multocida septic shock following liver transplantation treated with drotrecogin alpha (activated). Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100883688

Pasteurella multocida septic shock following liver transplantation treated with drotrecogin alpha (activated). Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Pasteurella multocida septic shock following liver transplantation treated with drotrecogin alpha (activated). Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Pasteurella multocida septic shock following liver transplantation treated with drotrecogin alpha (activated).

AFFILIATION: Department of Surgery, McGill University, Montreal, Quebec, Canada.

Country: Denmark

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Transpl Infect Dis

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Pasteurella multocida septic shock following liver transplantation treated with drotrecogin alpha activated Related Publications

• Adalimumab for treatment of pyoderma gangrenosum.
• Application of qisas and diyat act's terms for reporting in current forensic radiology practice.
• Blood pressure management in patients with acute stroke: pathophysiology and treatment strategies.
• Changes in serum calcium levels associated with catheter-based cerebral angiography.
• Chronic effects of type 2 diabetes mellitus on cardiac muscle contraction in the Goto-Kakizaki rat.
• Clinical and neurological study of women with precatamenial epilepsy.
• Community Eye Health MSc dissertation summaries from the Pakistan Institute of Community Ophthalmology Peshawar, Pakistan.
• Early detection of typhoid by polymerase chain reaction.
• Effect of metformin on clastogenic and biochemical changes induced by adriamycin in Swiss albino mice.
• Genetics support to primary care practitioners - a demonstration project.
• I was being myself but being an actor too: The experience of a Black male in interracial psychotherapy.
• Intra-arterial thrombolysis for central retinal artery occlusion in United States: Nationwide In-patient Survey 2001-2003.
• Intrathoracic lipoma in a child.
• Melanoma presenting as pericardial effusion.
• Muchausen's syndrome.
• Multidisciplinary evaluation of patients with psoriasis presenting with musculoskeletal pain: a dermatology: rheumatology clinic experience.
• Neuroleptic malignant syndrome: Risk factors!
• Pasteurella multocida septic shock following liver transplantation treated with drotrecogin alpha (activated).
• Patterns of pediatric emergency room visits at King Khalid University Hospital, Riyadh.
• Preliminary experience with intra-arterial nicardipine in patients with acute ischemic stroke.
• Protein-DNA interactions at the Sulfolobus spindle-shaped virus-1 (SSV1) T5 and T6 gene promoters.
• Questionable seasonality of mania.
• Screening for iron deficiency anemia in a well baby clinic.
• Screening strategies for familial paragangliomas.
• Stenting of a stenosed modified Blalock Taussig shunt after Norwood-I palliation for hypoplastic left heart.
• The use of stem cells' hematopoietic stimulating factors therapy following spinal cord injury.
• Training a cataract surgeon.
• Training to meet the need for refractive error services.
• Trihexyphenidyl (artane) abuse among Saudi psychiatric patients.
• True malignant mixed tumor of parotid.